Aptalis Pharmaceutical Technologies Premium Plus listing

100 Somerset Corporate Blvd.
United States

Tel: +1 908-927-9600

Website: http://www.AptalisPharmaceuticalTechnologies.com
Email: [email protected]


Aptalis Pharmaceutical Technologies (formerly Eurand Pharmaceutical Technologies) develops and manufactures differentiated oral pharmaceutical products using a broad range of proprietary technologies from three major platforms:

  • Customized Drug Release
  • Bioavailability Enhancement
  • Taste Masking and ODTs

Through our collaboration agreements, we offer resources for the development of new product formulations and licensing of existing prescription and OTC drugs.  Our team of formulation experts draw upon years of experience and a track record of success to meet our partners’ formulation challenges, by applying our expertise in bioavailability enhancement of poorly soluble drugs, custom drug release profiles, and taste-masking for dosage forms including orally disintegrating tablets (ODTs). 

We have a multinational infrastructure with integrated R&D and manufacturing facilities in the U.S. and Europe, allowing us to offer global solutions to companies in various regions around the world.  Visit us at www.AptalisPharmaceuticalTechnologies.com

Upcoming events

  • Drug Delivery and Formulation Summit - Berlin, February 18 – 20, 2013
  • Bio-Europe - Barcelona, March 11 – 13, 2013
  • Bio International - Chicago, April 22- 25, 2013
  • Controlled Release Society (CRS) - Honolulu Hawaii, July 21– 24, 2013
  • IPLS - Dublin, September 18 – 20, 2013
  • CPhI - Frankfurt, Germany, October 22-24, 2013

Listed in categories

Outsourcing | Other |

Related posts:

  • No related posts found